Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

RayzeBio Q3 EPS $(1.26) Up From $(6.55) YoY

Author: Benzinga Newsdesk | November 13, 2023 06:09pm
RayzeBio (NASDAQ:RYZB) reported quarterly losses of $(1.26) per share. This is a 80.76 percent increase over losses of $(6.55) per share from the same period last year.

Posted In: RYZB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist